ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

17.37

+0.59 (3.53%)

Jun 5, 2026, 4:00 PM EDT - Market closed

3.53% (1D)

Assets	$2.66M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	145,548
Dividend (ttm)	$0.87
Dividend Yield	4.99%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	5,749
Open	16.92
Previous Close	16.78
Day's Range	16.92 - 17.39
52-Week Low	15.90
52-Week High	36.85
Beta	-1.20
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange NASDAQ

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-200.51% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-34.47%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-36.90%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-38.11%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-38.84%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-52.19%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.13714	Mar 31, 2026
Dec 24, 2025	$0.20514	Dec 31, 2025
Sep 24, 2025	$0.30854	Sep 30, 2025
Jun 25, 2025	$0.2161	Jul 1, 2025
Mar 26, 2025	$0.2651	Apr 1, 2025
Dec 23, 2024	$0.41277	Dec 31, 2024

Full Dividend History

Performance

BIS had a total return of -50.40% in the past year, including dividends. Since the fund's inception, the average annual return has been -31.87%.